Changeflow GovPing Healthcare & Life Sciences Kumquat Biosciences EP4203952A1 Heterocyclic Co...
Routine Rule Added Final

Kumquat Biosciences EP4203952A1 Heterocyclic Compounds Patent

Favicon for changeflow.com EPO Patent Bulletin - Organic Chemistry (C07D)
Published
Detected
Email

Summary

Kumquat Biosciences Inc. has obtained European patent publication EP4203952A1 for heterocyclic compounds and uses thereof, covering compositions with potential therapeutic applications. The patent names five inventors — Liu Yi, Ren Pingda, Li Liansheng, Zhu Zhimin, and Zhu Xiuwen — and was published on April 15, 2026. The application is designated across 31 European states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands, among others.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Organic Chemistry (C07D) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.

What changed

The European Patent Office published EP4203952A1, a European patent application by Kumquat Biosciences Inc. covering heterocyclic compounds and their uses, with an April 15, 2026 publication date. The patent names five individual inventors and carries multiple IPC classifications relating to heterocyclic chemistry and pharmaceutical compositions.

Pharmaceutical and biotechnology companies developing compounds in the C07D chemical space should assess freedom-to-operate implications of EP4203952A1 in designated states. The designated states span 31 European jurisdictions, and the patent's broad C07D 401/14, 403/14, and 417/14 classification coverage may indicate claims across multiple heterocyclic compound families.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

HETEROCYCLIC COMPOUNDS AND USES THEREOF

Publication EP4203952A1 Kind: A1 Apr 15, 2026

Applicants

Kumquat Biosciences Inc.

Inventors

LIU, Yi, REN, Pingda, LI, Liansheng, ZHU, Zhimin, ZHU, Xiuwen

IPC Classifications

A61K 31/4375 20060101AFI20241107BHEP C07D 401/14 20060101ALI20241107BHEP C07D 403/14 20060101ALI20241107BHEP C07D 417/14 20060101ALI20241107BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4203952A1

Who this affects

Applies to
Pharmaceutical companies Manufacturers Investors
Industry sector
3254.1 Biotechnology
Activity scope
Patent grant Intellectual property registration Drug discovery
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare Securities

Get alerts for this source

We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!